Ticker
BRTXCompany Name
BIORESTORATIVE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 281.31K | $ -10.72M | $ -10.44M |
3/31/2025 | $ 313.51K | $ -12.1M | $ -11.78M |
12/31/2024 | $ 340.5K | $ -8.98M | $ -8.64M |
9/30/2024 | $ 296.43K | $ -5.99M | $ -5.7M |
6/30/2024 | $ 280.87K | $ -7.89M | $ -7.61M |
3/31/2024 | $ 266.46K | $ -6.94M | $ -6.67M |
12/31/2023 | $ 256.05K | $ -14.42M | $ -14.16M |
9/30/2023 | $ 314.94K | $ -16.23M | $ -15.92M |
6/30/2023 | $ 304.02K | $ -17.87M | $ -17.57M |
3/31/2023 | $ 294.01K | $ -19.42M | $ -19.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for BIORESTORATIVE THERAPIES INC is calculated as follows: EBIT [ $ -13.18M ] + DepAmor [ $ 234.82K ]
(=) EBITDA [ $ -12.95M ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.24K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.9M |
median | $ 8.92M |
std | $ 167.01M |